The nexobrid market research report is one of a series of new reports that provides nexobrid market statistics, including the nexobrid industry global market size, regional shares, competitors with the nexobrid market share, detailed nexobrid market segments, market trends, and opportunities, and any further data you may need to thrive in the nexobrid industry. This nexobrid market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The growth in the forecast period can be attributed to the growing demand for faster and more effective burn healing solutions, increasing government initiatives for burn care, enhanced accessibility to advanced medical treatments, expansion of healthcare facilities in low- and middle-income countries, growing awareness of the benefits of enzymatic debridement. Major trends in the forecast period include growth in the adoption of advanced wound care products, rising preference for minimally invasive treatments, adoption of AI-driven technologies in burn treatment, integration of regenerative medicine in burn recovery, and collaborative partnerships between governments and healthcare providers.
The rising prevalence of burn injuries is expected to drive the growth of the Nexobrid market. Burn injuries involve physical damage to the skin or other tissues, resulting in tissue destruction, pain, and impaired function. Occupations in industries such as construction, manufacturing, and healthcare pose higher burn injury risks due to exposure to open flames, hot surfaces, and hazardous chemicals. Nexobrid supports burn recovery by efficiently removing eschar from burn wounds, accelerating healing, and reducing the need for surgery, ultimately improving patient outcomes. For instance, in October 2023, the World Health Organization reported that around 180,000 deaths occur each year due to burns, with most occurring in low- and middle-income countries. As a result, the increasing prevalence of burn injuries is expected to drive Nexobrid market growth.
The development of advanced eschar removal drug products is a key trend in the Nexobrid market. These drugs are designed to break down dead tissue formed over burns or wounds, helping to facilitate healing and prevent infections. They support burn care by promoting tissue regeneration and may reduce the need for surgical debridement. In December 2022, MediWound Ltd., an Israel-based biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) had approved NexoBrid (anacaulase-bcdb) for the removal of eschar in adults with deep partial-thickness or full-thickness thermal burns. This treatment features a unique proteolytic enzyme formulation that effectively removes burn eschar in four hours while preserving healthy tissue. NexoBrid offers a non-surgical, quick, and efficient alternative for burn treatment, and it has been approved in over 43 countries, including the United States. It is also supported by the Biomedical Advanced Research and Development Authority (BARDA) to enhance burn care and improve emergency preparedness.
In December 2022, Bharat Serums and Vaccines (BSV) Limited, an India-based biopharmaceutical company, partnered with MediWound Ltd. to expand burn care in India by improving access to NexoBrid. The partnership focuses on enhancing burn management, especially for women and security personnel, to address critical gaps in burn care and improve patient outcomes across the country. MediWound Ltd., based in Israel, is the manufacturer of NexoBrid.
The key company operating in the nexobrid market is MediWound Ltd.
North America was the largest region in the nexobrid market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in nexobrid report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the nexobrid market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.
Nexobrid is a topical enzymatic debridement agent designed for the treatment of severe burns. It selectively removes eschar while preserving healthy tissue, accelerating wound healing, and reducing the need for surgical procedures. This advanced formulation promotes better recovery outcomes and offers a non-invasive solution for burn care.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The main formulations of Nexobrid are topical gel, spray, and ointment. The topical gel formulation is intended for direct application to the skin, efficiently delivering active ingredients to the affected area to promote healing. It is used in several clinical indications, such as burn care, chronic wound care, and trauma care. Nexobrid is distributed through various channels, including hospitals, ambulatory surgical centers (ASCs), retail pharmacies, and online pharmacies, and is used by a wide range of end users, including adults, pediatric patients, and the elderly.
The nexobrid market consists of sales of cream, liquid solution, and powder. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The growth in the forecast period can be attributed to the growing demand for faster and more effective burn healing solutions, increasing government initiatives for burn care, enhanced accessibility to advanced medical treatments, expansion of healthcare facilities in low- and middle-income countries, growing awareness of the benefits of enzymatic debridement. Major trends in the forecast period include growth in the adoption of advanced wound care products, rising preference for minimally invasive treatments, adoption of AI-driven technologies in burn treatment, integration of regenerative medicine in burn recovery, and collaborative partnerships between governments and healthcare providers.
The rising prevalence of burn injuries is expected to drive the growth of the Nexobrid market. Burn injuries involve physical damage to the skin or other tissues, resulting in tissue destruction, pain, and impaired function. Occupations in industries such as construction, manufacturing, and healthcare pose higher burn injury risks due to exposure to open flames, hot surfaces, and hazardous chemicals. Nexobrid supports burn recovery by efficiently removing eschar from burn wounds, accelerating healing, and reducing the need for surgery, ultimately improving patient outcomes. For instance, in October 2023, the World Health Organization reported that around 180,000 deaths occur each year due to burns, with most occurring in low- and middle-income countries. As a result, the increasing prevalence of burn injuries is expected to drive Nexobrid market growth.
The development of advanced eschar removal drug products is a key trend in the Nexobrid market. These drugs are designed to break down dead tissue formed over burns or wounds, helping to facilitate healing and prevent infections. They support burn care by promoting tissue regeneration and may reduce the need for surgical debridement. In December 2022, MediWound Ltd., an Israel-based biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) had approved NexoBrid (anacaulase-bcdb) for the removal of eschar in adults with deep partial-thickness or full-thickness thermal burns. This treatment features a unique proteolytic enzyme formulation that effectively removes burn eschar in four hours while preserving healthy tissue. NexoBrid offers a non-surgical, quick, and efficient alternative for burn treatment, and it has been approved in over 43 countries, including the United States. It is also supported by the Biomedical Advanced Research and Development Authority (BARDA) to enhance burn care and improve emergency preparedness.
In December 2022, Bharat Serums and Vaccines (BSV) Limited, an India-based biopharmaceutical company, partnered with MediWound Ltd. to expand burn care in India by improving access to NexoBrid. The partnership focuses on enhancing burn management, especially for women and security personnel, to address critical gaps in burn care and improve patient outcomes across the country. MediWound Ltd., based in Israel, is the manufacturer of NexoBrid.
The key company operating in the nexobrid market is MediWound Ltd.
North America was the largest region in the nexobrid market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in nexobrid report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the nexobrid market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.
Nexobrid is a topical enzymatic debridement agent designed for the treatment of severe burns. It selectively removes eschar while preserving healthy tissue, accelerating wound healing, and reducing the need for surgical procedures. This advanced formulation promotes better recovery outcomes and offers a non-invasive solution for burn care.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The main formulations of Nexobrid are topical gel, spray, and ointment. The topical gel formulation is intended for direct application to the skin, efficiently delivering active ingredients to the affected area to promote healing. It is used in several clinical indications, such as burn care, chronic wound care, and trauma care. Nexobrid is distributed through various channels, including hospitals, ambulatory surgical centers (ASCs), retail pharmacies, and online pharmacies, and is used by a wide range of end users, including adults, pediatric patients, and the elderly.
The nexobrid market consists of sales of cream, liquid solution, and powder. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Nexobrid Market Characteristics4. Nexobrid Market Trends And Strategies5. Nexobrid Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market7. Global Nexobrid Pricing Analysis & Forecasts30. Global Nexobrid Market Competitive Benchmarking And Dashboard31. Key Mergers And Acquisitions In The Nexobrid Market32. Recent Developments In The Nexobrid Market
3. Nexobrid Market Biologic Drug Characteristics
6. Global Nexobrid Growth Analysis And Strategic Analysis Framework
8. Nexobrid Market Segmentation
9. Global Nexobrid Epidemiology Of Clinical Indications
10. Nexobrid Market Regional And Country Analysis
11. Asia-Pacific Nexobrid Market
12. China Nexobrid Market
13. India Nexobrid Market
14. Japan Nexobrid Market
15. Australia Nexobrid Market
16. South Korea Nexobrid Market
17. Western Europe Nexobrid Market
18. UK Nexobrid Market
19. Germany Nexobrid Market
20. France Nexobrid Market
21. Eastern Europe Nexobrid Market
22. North America Nexobrid Market
23. USA Nexobrid Market
24. Canada Nexobrid Market
25. South America Nexobrid Market
26. Middle East Nexobrid Market
27. Africa Nexobrid Market
28. Nexobrid Market Competitive Landscape And Company Profiles
29. Global Nexobrid Market Pipeline Analysis
33. Nexobrid Market High Potential Countries, Segments and Strategies
34. Appendix
Executive Summary
Nexobrid Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on nexobrid market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for nexobrid ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The nexobrid market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Formulation: Topical Gel; Spray; Ointment2) By Clinical Indication: Burn Care; Chronic Wound Care; Trauma Care
3) By Distribution Channel: Hospitals; Ambulatory Surgical Centers (ASCs); Retail Pharmacies; Online Pharmacies
4) By End-User: Adult; Pediatric; Geriatric
Key Companies Profiled: MediWound Ltd.
Countries: Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- MediWound Ltd.